

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.75253524 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.57453274 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 9.49992869 |
| 4 | drug catabolic process (GO:0042737) | 9.31688552 |
| 5 | glyoxylate metabolic process (GO:0046487) | 8.41530687 |
| 6 | complement activation, alternative pathway (GO:0006957) | 8.12376449 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.11462319 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 8.11462319 |
| 9 | regulation of fibrinolysis (GO:0051917) | 8.10658977 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 7.40768489 |
| 11 | regulation of protein activation cascade (GO:2000257) | 7.36335119 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.33460118 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 7.33460118 |
| 14 | ethanol oxidation (GO:0006069) | 7.18067734 |
| 15 | regulation of complement activation (GO:0030449) | 7.01199390 |
| 16 | protein carboxylation (GO:0018214) | 6.48109580 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.48109580 |
| 18 | urea metabolic process (GO:0019627) | 6.47588252 |
| 19 | drug metabolic process (GO:0017144) | 6.46950040 |
| 20 | fibrinolysis (GO:0042730) | 6.32387648 |
| 21 | negative regulation of sterol transport (GO:0032372) | 6.25640116 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 6.25640116 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 6.24019214 |
| 24 | oxidative demethylation (GO:0070989) | 6.23860602 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 6.12725664 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.86389808 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.86079720 |
| 28 | blood coagulation, intrinsic pathway (GO:0007597) | 5.85446758 |
| 29 | bile acid biosynthetic process (GO:0006699) | 5.83448114 |
| 30 | imidazole-containing compound metabolic process (GO:0052803) | 5.77926961 |
| 31 | ethanol metabolic process (GO:0006067) | 5.77751538 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 5.61028495 |
| 33 | urea cycle (GO:0000050) | 5.59809848 |
| 34 | cellular glucuronidation (GO:0052695) | 5.53261793 |
| 35 | glucuronate metabolic process (GO:0019585) | 5.28671479 |
| 36 | uronic acid metabolic process (GO:0006063) | 5.28671479 |
| 37 | phenylpropanoid metabolic process (GO:0009698) | 5.27744809 |
| 38 | glycine metabolic process (GO:0006544) | 5.26541539 |
| 39 | regulation of plasminogen activation (GO:0010755) | 5.22699359 |
| 40 | bile acid metabolic process (GO:0008206) | 5.11443766 |
| 41 | S-adenosylmethionine metabolic process (GO:0046500) | 5.04487272 |
| 42 | protein activation cascade (GO:0072376) | 5.03445732 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.98255952 |
| 44 | complement activation (GO:0006956) | 4.74799524 |
| 45 | complement activation, classical pathway (GO:0006958) | 4.70195765 |
| 46 | negative regulation of blood coagulation (GO:0030195) | 4.68275435 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.68275435 |
| 48 | phospholipid efflux (GO:0033700) | 4.62563549 |
| 49 | bile acid and bile salt transport (GO:0015721) | 4.62495102 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 4.57403121 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 4.57403121 |
| 52 | tryptophan catabolic process (GO:0006569) | 4.57403121 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.54204599 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.54204599 |
| 55 | glutamate metabolic process (GO:0006536) | 4.46605678 |
| 56 | regulation of humoral immune response (GO:0002920) | 4.42654944 |
| 57 | opsonization (GO:0008228) | 4.41702954 |
| 58 | alkaloid metabolic process (GO:0009820) | 4.39656278 |
| 59 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.36855398 |
| 60 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.36855398 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 4.35109838 |
| 62 | macromolecular complex remodeling (GO:0034367) | 4.35109838 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 4.35109838 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.31009935 |
| 65 | alpha-amino acid catabolic process (GO:1901606) | 4.29837510 |
| 66 | cholesterol efflux (GO:0033344) | 4.28527107 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 4.27883197 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.25705159 |
| 69 | negative regulation of protein activation cascade (GO:2000258) | 4.24474596 |
| 70 | negative regulation of coagulation (GO:0050819) | 4.24074421 |
| 71 | aromatic amino acid family metabolic process (GO:0009072) | 4.17922502 |
| 72 | negative regulation of wound healing (GO:0061045) | 4.17522216 |
| 73 | high-density lipoprotein particle remodeling (GO:0034375) | 4.17246658 |
| 74 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.14842727 |
| 75 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.14842727 |
| 76 | acute-phase response (GO:0006953) | 4.12749843 |
| 77 | cytolysis (GO:0019835) | 4.06433207 |
| 78 | positive regulation of blood coagulation (GO:0030194) | 4.02807961 |
| 79 | positive regulation of hemostasis (GO:1900048) | 4.02807961 |
| 80 | arginine metabolic process (GO:0006525) | 4.00893500 |
| 81 | reverse cholesterol transport (GO:0043691) | 3.93659250 |
| 82 | tryptophan metabolic process (GO:0006568) | 3.89585079 |
| 83 | flavonoid metabolic process (GO:0009812) | 3.83071113 |
| 84 | ketone body metabolic process (GO:1902224) | 3.81786239 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.79442756 |
| 86 | intestinal cholesterol absorption (GO:0030299) | 3.73917334 |
| 87 | regulation of cholesterol esterification (GO:0010872) | 3.72066381 |
| 88 | positive regulation of coagulation (GO:0050820) | 3.69116886 |
| 89 | response to mercury ion (GO:0046689) | 3.67441065 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.67410178 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.62863611 |
| 92 | xenobiotic metabolic process (GO:0006805) | 3.60476407 |
| 93 | cysteine metabolic process (GO:0006534) | 3.59093198 |
| 94 | negative regulation of complement activation (GO:0045916) | 3.56819248 |
| 95 | sodium-independent organic anion transport (GO:0043252) | 3.54358621 |
| 96 | heme transport (GO:0015886) | 3.52233012 |
| 97 | hormone catabolic process (GO:0042447) | 3.42513331 |
| 98 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.42459925 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 3.40842552 |
| 100 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.34131880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07117356 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.65655937 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.57807096 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.48141421 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.12249859 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.42610059 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.21889806 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.75685649 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.50628127 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.15186788 |
| 11 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.14177004 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.04284752 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6015860 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.96409455 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.89981194 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81451060 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68625638 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.56665714 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.51556150 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42685180 |
| 21 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.40049679 |
| 22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.36120669 |
| 23 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28657285 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23052795 |
| 25 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22019603 |
| 26 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.21280710 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18626551 |
| 28 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02558155 |
| 29 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01793583 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01708940 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.00592960 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97770478 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97132748 |
| 34 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.95769841 |
| 35 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94109077 |
| 36 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94028080 |
| 37 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.93943503 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92892357 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92323822 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92290934 |
| 41 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.91999898 |
| 42 | CBP_21632823_ChIP-Seq_H3396_Human | 0.91558535 |
| 43 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.91212103 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90120090 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89721095 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88668453 |
| 47 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85093570 |
| 48 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84026145 |
| 49 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83696201 |
| 50 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83149956 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82402385 |
| 52 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82399610 |
| 53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82222678 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81819234 |
| 55 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81617527 |
| 56 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.81366749 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.80442633 |
| 58 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.78012394 |
| 59 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.77809585 |
| 60 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.77379296 |
| 61 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77359315 |
| 62 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.76547032 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76214221 |
| 64 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76077411 |
| 65 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75547350 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75476886 |
| 67 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.74923244 |
| 68 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.73433282 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73251500 |
| 70 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.72114303 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71941514 |
| 72 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.71842990 |
| 73 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.71842990 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.71653180 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.71653180 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 0.70113991 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.70101839 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.69421579 |
| 79 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.69278241 |
| 80 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.68950489 |
| 81 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.68863249 |
| 82 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.68484934 |
| 83 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.67978933 |
| 84 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.67772632 |
| 85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.67519337 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 0.67450101 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 0.67423826 |
| 88 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66996204 |
| 89 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.66882314 |
| 90 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.66063187 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.65955687 |
| 92 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.65264262 |
| 93 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.63495219 |
| 94 | NCOR_22424771_ChIP-Seq_293T_Human | 0.62755666 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62313877 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.62143493 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.61920995 |
| 98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.60392511 |
| 99 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.59902897 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.59789394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.47347416 |
| 2 | MP0005360_urolithiasis | 6.55213220 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37994334 |
| 4 | MP0003195_calcinosis | 5.98224143 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.88017972 |
| 6 | MP0005365_abnormal_bile_salt | 5.45637396 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.19387903 |
| 8 | MP0003252_abnormal_bile_duct | 4.10750338 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.06203898 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.96346389 |
| 11 | MP0003868_abnormal_feces_composition | 2.84177516 |
| 12 | MP0009697_abnormal_copulation | 2.66399041 |
| 13 | MP0005332_abnormal_amino_acid | 2.54492846 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.36555337 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.07480955 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.01544686 |
| 17 | MP0010368_abnormal_lymphatic_system | 1.83768753 |
| 18 | MP0000609_abnormal_liver_physiology | 1.79004227 |
| 19 | MP0009840_abnormal_foam_cell | 1.78502780 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.70926359 |
| 21 | MP0001764_abnormal_homeostasis | 1.64090860 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.38902097 |
| 23 | MP0005670_abnormal_white_adipose | 1.35239842 |
| 24 | MP0009053_abnormal_anal_canal | 1.24310024 |
| 25 | MP0005408_hypopigmentation | 1.18047966 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.16922157 |
| 27 | MP0001661_extended_life_span | 1.11896074 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.10908996 |
| 29 | MP0002132_abnormal_respiratory_system | 1.08124172 |
| 30 | MP0008872_abnormal_physiological_respon | 1.07741299 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.07172897 |
| 32 | MP0000598_abnormal_liver_morphology | 1.03226131 |
| 33 | MP0009764_decreased_sensitivity_to | 0.99285242 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97172277 |
| 35 | MP0002971_abnormal_brown_adipose | 0.93966012 |
| 36 | MP0002282_abnormal_trachea_morphology | 0.89133173 |
| 37 | MP0002168_other_aberrant_phenotype | 0.86551104 |
| 38 | MP0003879_abnormal_hair_cell | 0.86338173 |
| 39 | MP0005376_homeostasis/metabolism_phenot | 0.85074407 |
| 40 | MP0005395_other_phenotype | 0.84314729 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.81220090 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 0.76279332 |
| 43 | MP0009763_increased_sensitivity_to | 0.75881837 |
| 44 | MP0003186_abnormal_redox_activity | 0.74708071 |
| 45 | MP0005535_abnormal_body_temperature | 0.72765709 |
| 46 | MP0005266_abnormal_metabolism | 0.72240683 |
| 47 | MP0008469_abnormal_protein_level | 0.69730744 |
| 48 | MP0002249_abnormal_larynx_morphology | 0.67490108 |
| 49 | MP0005334_abnormal_fat_pad | 0.67051954 |
| 50 | MP0003690_abnormal_glial_cell | 0.66468947 |
| 51 | MP0005083_abnormal_biliary_tract | 0.64262106 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 0.62779820 |
| 53 | MP0005187_abnormal_penis_morphology | 0.62080099 |
| 54 | MP0001915_intracranial_hemorrhage | 0.61615902 |
| 55 | MP0004043_abnormal_pH_regulation | 0.60308369 |
| 56 | MP0005451_abnormal_body_composition | 0.59215658 |
| 57 | MP0008874_decreased_physiological_sensi | 0.56250412 |
| 58 | MP0004130_abnormal_muscle_cell | 0.55312333 |
| 59 | MP0000604_amyloidosis | 0.55188871 |
| 60 | MP0003638_abnormal_response/metabolism_ | 0.54749398 |
| 61 | MP0003011_delayed_dark_adaptation | 0.52795581 |
| 62 | MP0005464_abnormal_platelet_physiology | 0.45522800 |
| 63 | MP0005448_abnormal_energy_balance | 0.44956538 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.44259116 |
| 65 | MP0000566_synostosis | 0.43571931 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 0.43544275 |
| 67 | MP0001986_abnormal_taste_sensitivity | 0.40302554 |
| 68 | MP0005646_abnormal_pituitary_gland | 0.40209919 |
| 69 | MP0001756_abnormal_urination | 0.40196216 |
| 70 | MP0009785_altered_susceptibility_to | 0.40157268 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.39066198 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.38466136 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.38120002 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.37003318 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.37003318 |
| 76 | MP0002928_abnormal_bile_duct | 0.36376608 |
| 77 | MP0005166_decreased_susceptibility_to | 0.35486384 |
| 78 | MP0003718_maternal_effect | 0.35161863 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.34465546 |
| 80 | MP0004883_abnormal_blood_vessel | 0.34129869 |
| 81 | MP0003953_abnormal_hormone_level | 0.34000603 |
| 82 | MP0000249_abnormal_blood_vessel | 0.33402608 |
| 83 | MP0003075_altered_response_to | 0.31788645 |
| 84 | MP0000639_abnormal_adrenal_gland | 0.31705327 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.31264747 |
| 86 | MP0005647_abnormal_sex_gland | 0.31066560 |
| 87 | MP0005164_abnormal_response_to | 0.29306641 |
| 88 | MP0005023_abnormal_wound_healing | 0.28904865 |
| 89 | MP0009115_abnormal_fat_cell | 0.25809931 |
| 90 | MP0000467_abnormal_esophagus_morphology | 0.25792920 |
| 91 | MP0002970_abnormal_white_adipose | 0.24104427 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.23486451 |
| 93 | MP0003633_abnormal_nervous_system | 0.22488676 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.21336154 |
| 95 | MP0003959_abnormal_lean_body | 0.21304878 |
| 96 | MP0008873_increased_physiological_sensi | 0.20153710 |
| 97 | MP0005377_hearing/vestibular/ear_phenot | 0.19847124 |
| 98 | MP0003878_abnormal_ear_physiology | 0.19847124 |
| 99 | MP0001851_eye_inflammation | 0.18040365 |
| 100 | MP0004142_abnormal_muscle_tone | 0.17495889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.67336408 |
| 2 | Complement deficiency (HP:0004431) | 9.61055933 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 9.31837283 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.52289211 |
| 5 | Abnormality of complement system (HP:0005339) | 7.65070012 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.22187613 |
| 7 | Joint hemorrhage (HP:0005261) | 6.51429684 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 6.37322359 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 6.31739928 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.88264432 |
| 11 | Xanthomatosis (HP:0000991) | 5.36926232 |
| 12 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.22834276 |
| 13 | Glomerulonephritis (HP:0000099) | 4.97996260 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 4.96420741 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.54145432 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 4.26352908 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.21185152 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.06175193 |
| 19 | Spontaneous abortion (HP:0005268) | 3.95128546 |
| 20 | Nephritis (HP:0000123) | 3.78084339 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.75275959 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.71471100 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.66697042 |
| 24 | Hyperglycinemia (HP:0002154) | 3.49297861 |
| 25 | Delayed CNS myelination (HP:0002188) | 3.40796198 |
| 26 | Fair hair (HP:0002286) | 3.27459831 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.24631539 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.18377884 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18377884 |
| 30 | Hyperammonemia (HP:0001987) | 3.15293658 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.10594412 |
| 32 | Neonatal hypoglycemia (HP:0001998) | 3.08333797 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.02977077 |
| 34 | Mitral stenosis (HP:0001718) | 3.01829218 |
| 35 | Fat malabsorption (HP:0002630) | 3.00968964 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 2.91339939 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.90289549 |
| 38 | Vascular calcification (HP:0004934) | 2.86053444 |
| 39 | Epidermoid cyst (HP:0200040) | 2.82457842 |
| 40 | Hyperglycinuria (HP:0003108) | 2.72697582 |
| 41 | Rickets (HP:0002748) | 2.70560206 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.67583913 |
| 43 | Osteomalacia (HP:0002749) | 2.66994672 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.64857842 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.58798606 |
| 46 | Gingival bleeding (HP:0000225) | 2.58609392 |
| 47 | Cardiovascular calcification (HP:0011915) | 2.51155730 |
| 48 | Thrombophlebitis (HP:0004418) | 2.50833523 |
| 49 | Hyperbilirubinemia (HP:0002904) | 2.49731064 |
| 50 | Steatorrhea (HP:0002570) | 2.46434941 |
| 51 | Menorrhagia (HP:0000132) | 2.36706637 |
| 52 | Purpura (HP:0000979) | 2.35916042 |
| 53 | Pulmonary embolism (HP:0002204) | 2.31800028 |
| 54 | Generalized hypopigmentation of hair (HP:0011358) | 2.30903872 |
| 55 | Hepatocellular carcinoma (HP:0001402) | 2.29537982 |
| 56 | Ketosis (HP:0001946) | 2.29401772 |
| 57 | Arthropathy (HP:0003040) | 2.27906489 |
| 58 | Metabolic acidosis (HP:0001942) | 2.23545972 |
| 59 | Hyperphosphaturia (HP:0003109) | 2.11688145 |
| 60 | Blue irides (HP:0000635) | 2.08146270 |
| 61 | Alkalosis (HP:0001948) | 2.04945454 |
| 62 | Abnormality of vitamin metabolism (HP:0100508) | 2.03456646 |
| 63 | Cholelithiasis (HP:0001081) | 2.01712277 |
| 64 | Glycosuria (HP:0003076) | 2.00798550 |
| 65 | Abnormality of urine glucose concentration (HP:0011016) | 2.00798550 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.4933058 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 1.94542142 |
| 68 | Cholecystitis (HP:0001082) | 1.94542142 |
| 69 | Hypophosphatemic rickets (HP:0004912) | 1.93423494 |
| 70 | Reduced antithrombin III activity (HP:0001976) | 1.92107248 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 1.90948108 |
| 72 | Cerebral palsy (HP:0100021) | 1.88762504 |
| 73 | Increased mean platelet volume (HP:0011877) | 1.86728645 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 1.85238369 |
| 75 | Irritability (HP:0000737) | 1.85162089 |
| 76 | Gangrene (HP:0100758) | 1.82803362 |
| 77 | Poikilocytosis (HP:0004447) | 1.80235933 |
| 78 | Myocardial infarction (HP:0001658) | 1.79700318 |
| 79 | Gout (HP:0001997) | 1.74827956 |
| 80 | Elevated alkaline phosphatase (HP:0003155) | 1.72839906 |
| 81 | Enlarged kidneys (HP:0000105) | 1.72707966 |
| 82 | Bifid scrotum (HP:0000048) | 1.72528820 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 1.69213115 |
| 84 | Hydroxyprolinuria (HP:0003080) | 1.69213115 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 1.67700654 |
| 86 | Abnormal urine phosphate concentration (HP:0012599) | 1.67601919 |
| 87 | Abnormal platelet function (HP:0011869) | 1.67109578 |
| 88 | Impaired platelet aggregation (HP:0003540) | 1.67109578 |
| 89 | Abnormal platelet volume (HP:0011876) | 1.66957987 |
| 90 | Bile duct proliferation (HP:0001408) | 1.66351809 |
| 91 | Abnormal biliary tract physiology (HP:0012439) | 1.66351809 |
| 92 | Hypochromic microcytic anemia (HP:0004840) | 1.66186513 |
| 93 | Lethargy (HP:0001254) | 1.66040708 |
| 94 | Joint swelling (HP:0001386) | 1.65257102 |
| 95 | Atrioventricular block (HP:0001678) | 1.65058118 |
| 96 | Pancreatitis (HP:0001733) | 1.62165292 |
| 97 | Increased serum ferritin (HP:0003281) | 1.62043425 |
| 98 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.62042762 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 1.60859965 |
| 100 | Epistaxis (HP:0000421) | 1.57922858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.41654493 |
| 2 | FRK | 4.97655424 |
| 3 | WNK3 | 3.71778627 |
| 4 | PIK3CG | 3.07282845 |
| 5 | BCKDK | 2.63993038 |
| 6 | FGFR4 | 2.34232375 |
| 7 | PIK3CA | 2.31822697 |
| 8 | CAMKK2 | 2.07717957 |
| 9 | PRKACG | 2.04132153 |
| 10 | PRKCG | 1.93088377 |
| 11 | INSRR | 1.89528887 |
| 12 | MAPK11 | 1.87783748 |
| 13 | TYK2 | 1.86891664 |
| 14 | ADRBK2 | 1.85559830 |
| 15 | TNK2 | 1.82281841 |
| 16 | PRKAA2 | 1.81074195 |
| 17 | LATS1 | 1.77569816 |
| 18 | SIK1 | 1.77025387 |
| 19 | NTRK3 | 1.73789677 |
| 20 | WNK4 | 1.72599513 |
| 21 | TAOK3 | 1.57464448 |
| 22 | MAP2K4 | 1.54890774 |
| 23 | OXSR1 | 1.53479019 |
| 24 | PDK2 | 1.41670570 |
| 25 | TRIB3 | 1.37915836 |
| 26 | NEK9 | 1.32460377 |
| 27 | GRK1 | 1.31204143 |
| 28 | PKN2 | 1.25093193 |
| 29 | IGF1R | 1.22223588 |
| 30 | PINK1 | 1.20695114 |
| 31 | ERBB2 | 1.19354253 |
| 32 | SGK2 | 1.17183722 |
| 33 | ACVR1B | 1.16424049 |
| 34 | NUAK1 | 1.12640853 |
| 35 | FGFR2 | 1.12494650 |
| 36 | CCNB1 | 1.05924712 |
| 37 | FER | 1.02673353 |
| 38 | TIE1 | 1.02444956 |
| 39 | BMPR1B | 0.99189910 |
| 40 | PRKG1 | 0.97907025 |
| 41 | RIPK1 | 0.95363971 |
| 42 | PRKACA | 0.94138999 |
| 43 | PRKAA1 | 0.92732770 |
| 44 | AKT3 | 0.92677453 |
| 45 | NLK | 0.88508833 |
| 46 | STK39 | 0.87522821 |
| 47 | CASK | 0.86966344 |
| 48 | SGK223 | 0.86913319 |
| 49 | SGK494 | 0.86913319 |
| 50 | JAK1 | 0.86638808 |
| 51 | MAP4K2 | 0.86121993 |
| 52 | PRKCZ | 0.80922611 |
| 53 | DAPK2 | 0.80635179 |
| 54 | SGK3 | 0.78885051 |
| 55 | CAMK1D | 0.78047528 |
| 56 | PDPK1 | 0.75735607 |
| 57 | CSNK1D | 0.74561038 |
| 58 | EPHA4 | 0.71760229 |
| 59 | FGFR3 | 0.70940173 |
| 60 | BRSK2 | 0.69853289 |
| 61 | PDK1 | 0.69488301 |
| 62 | ABL2 | 0.65786338 |
| 63 | MAP3K3 | 0.61972617 |
| 64 | CSF1R | 0.61000801 |
| 65 | PRKCA | 0.60627701 |
| 66 | PRKCB | 0.60409271 |
| 67 | SGK1 | 0.60053604 |
| 68 | MAPK4 | 0.59114245 |
| 69 | TNIK | 0.58758278 |
| 70 | EPHA3 | 0.58240664 |
| 71 | RPS6KA3 | 0.57614682 |
| 72 | MAPK7 | 0.57489822 |
| 73 | KDR | 0.56687877 |
| 74 | JAK2 | 0.55917325 |
| 75 | CAMK1G | 0.55475953 |
| 76 | PRKCE | 0.55223888 |
| 77 | PRKACB | 0.55047307 |
| 78 | MUSK | 0.54121441 |
| 79 | MAPK12 | 0.52774657 |
| 80 | PLK4 | 0.52398405 |
| 81 | CAMKK1 | 0.52147917 |
| 82 | CSNK1A1 | 0.49758764 |
| 83 | MAPKAPK3 | 0.49452465 |
| 84 | TGFBR2 | 0.48050228 |
| 85 | CSNK1E | 0.46190949 |
| 86 | MELK | 0.45855824 |
| 87 | PAK3 | 0.45725875 |
| 88 | MAPKAPK5 | 0.45472470 |
| 89 | ADRBK1 | 0.45115037 |
| 90 | BLK | 0.44054632 |
| 91 | CAMK4 | 0.43841217 |
| 92 | BCR | 0.42217964 |
| 93 | CSNK1G1 | 0.38655365 |
| 94 | NEK2 | 0.37727497 |
| 95 | CDK6 | 0.36799760 |
| 96 | CSNK2A1 | 0.36032757 |
| 97 | MST1R | 0.34604797 |
| 98 | GSK3A | 0.34385266 |
| 99 | MAP3K2 | 0.34317178 |
| 100 | CHUK | 0.34233941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.46613392 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.43881837 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.91489759 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.78150892 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.46169720 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.43133763 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18692030 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.88379883 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.85839029 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.83988648 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57733251 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.51418205 |
| 13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.49739047 |
| 14 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.47310234 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46667837 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.40564349 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.35537227 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22703874 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11367866 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09090259 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93501960 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.79420668 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.67840041 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.63096043 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59868860 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57414054 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53819984 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51146585 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.44249377 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40587441 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34080249 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33751072 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32855822 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.27477564 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24588660 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20379144 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12567322 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12323145 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 1.09835888 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03407006 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97340496 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97027679 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96380516 |
| 44 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93319485 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91837009 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91607960 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 0.87372316 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86491124 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86077280 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82159441 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78958925 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69252579 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68805604 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66821901 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64600163 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.53023410 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45533173 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39910120 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34826046 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30281896 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.25714147 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.24797261 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22378131 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18820691 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.16543183 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14990323 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14266566 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14078359 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.13253210 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.05072788 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04216062 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03891116 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03815178 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.03809683 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03343804 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.01278163 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01050407 |
| 78 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2639908 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2579837 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2426675 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2404563 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.2297654 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2206445 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2147760 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1991934 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1801078 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1762920 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1549890 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1442340 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1175791 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1148022 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | -0.1067557 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0913996 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0815262 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | -0.0796109 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0718630 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0711693 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0554942 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0503917 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | -0.0488932 |

